Last reviewed · How we verify

NCT04600765

hsCRP Clinical Inflammation Marker for Human Bisphenol A Food Contamination

Completed NA Last updated 27 January 2021
What this trial tests

NA trial testing hsCRP serum measurement of inflammation in Inflammation in 1 participant. Completed in 10 December 2019.

Timeline
25 November 2019
Primary endpoint
6 December 2019
10 December 2019

Quick facts

Lead sponsorCenter for Research on Environmental Chemicals in Humans
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationnon randomized
Designsingle group
Maskingnone
Primary purposebasic science
Enrollment1
Start date25 November 2019
Primary completion6 December 2019
Estimated completion10 December 2019
Sites1 location across United States

Drugs / interventions tested

Conditions studied

Sponsor

Center for Research on Environmental Chemicals in Humans

Who can join

Adults 60 to 70, male only, with Inflammation. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Dietary intervention studies thus far have failed to be replicable or causal.This is particularly relevant regarding plastic-derived chemicals (PDCs),This first-of-a-kind dietary intervention study explores a potential causal relationship between human serum levels of BPA and High-Sensitivity C-Reactive Protein (hsCRP)

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Inflammation

Currently open trials in the same condition.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04600765.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing